Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development
Theranostics · 2024 · 14 (8) · 3300-3316
DOI: 10.7150/thno.96027 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, 2024. Verfasst von Dongxi Xiang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Shanghai Jiaotong University School of Medicine, Shanghai 200232, PRC. Hauptthemen laut MEDLINE: Antineoplastic Agents, Drug Development, Neoplasms, Organoids. Die Arbeit wurde bisher 119-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Shanghai Jiaotong University School of Medicine, Shanghai 200232, PRC.
- Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200127, PRC.
- Department of Oncology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai 200233 PRC.
- Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200125, PRC.
- National Center of Stomatology, National Clinical Research Center for Oral Disease, Shanghai 200011, PRC.
- Department of Oncology, Ren Ji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200127, PRC.
Zitieren
APA
Xiang, D., He, A., Zhou, R., Wang, Y., Xiao, X., Gong, T., Kang, W., Lin, X., Wang, X., PDO-based DST Consortium, Liu, L., Chen, Y. G., Gao, S., & Liu, Y. (2024). Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development. Theranostics, 14(8), 3300-3316. https://doi.org/10.7150/thno.96027
Vancouver
Xiang D, He A, Zhou R, Wang Y, Xiao X, Gong T, et al. Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development. Theranostics. 2024;14(8):3300-3316. doi:10.7150/thno.96027
BibTeX
@article{Xiang2024,
author = {Xiang, Dongxi and He, Aina and Zhou, Rong and Wang, Yonggang and Xiao, Xiuying and Gong, Ting and Kang, Wenyan and Lin, Xiaolin and Wang, Xiaochen and PDO-based DST Consortium, PDO-based DST Consortium and Liu, Lianxin and Chen, Ye-Guang and Gao, Shaorong and Liu, Yingbin},
title = {Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development},
journal = {Theranostics},
year = {2024},
volume = {14},
number = {8},
pages = {3300--3316},
doi = {10.7150/thno.96027}
}
EUVIMED